Position in LQDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,770
-$7,948 QoQ
Shares Held
110
-75.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#303
of 333 holders
Holding Since
Dec 2024
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Aster Capital Management (DIFC) Ltd holds $908,587 across 11 Drug Manufacturers - Specialty & Generic names. LQDA ranks #5 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,078 | $584,092 | |
| 2 | DERM |
Journey Medical Corp
|
30,720 | $217,497 | |
| 3 | VTRS |
Viatris Inc
|
3,589 | $56,993 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
288 | $13,613 | |
| 5 | LQDA |
Liquidia Corp
This page
|
110 | $8,770 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
393 | $7,058 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
202 | $5,124 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
134 | $4,850 |
All Filings in LQDA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,770 | 110 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,718 | 443 | Shares | Sole | 2026-05-13 | |
| 2024-12-31 | $14,570 | 1,239 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||